top of page

Korea Must Support Researchers' Entrepreneurship and Establish a Technology Transfer Organization

"Fostering Innovation and Collaboration: Insights from Leading Experts in Biotechnology"


For the growth and innovation of Korea's biotechnology industry, collaboration between academia, industry, and research institutions, along with creative innovation, is essential. While the Korean biotechnology industry has made significant strides in manufacturing, there are still many areas, particularly in novel drug development and other innovative domains, where it falls short. This gap exists primarily due to the lack of a solid foundation and infrastructure for fostering innovation.

On this occasion, I had the privilege of engaging in discussions with ten eminent experts in the field of biotechnology. The panel included Subra Suresh, Chairman of the Hewlett Packard Enterprise Board and a Professor at Stanford University School of Medicine; Jeffrey Glenn, Professor at Stanford University School of Medicine; Paul Liu, Deputy Chief of the Genetics and Molecular Biology Branch at the National Human Genome Research Institute; Sean Patel, Entrepreneur at RecNeuro; Gareth Stockwell, Professor at the National University of Singapore School of Medicine; Mordechai Sheves, Vice President of Technology Transfer at the Weizmann Institute of Science; Roland Ilagan, Chief Medical Officer at Amazon Web Services; Mark Koen, Dean of the University of Illinois College of Medicine; and Uzi Sofer, CEO of AlphaTau.

Together with these distinguished experts, we emphasized the pivotal role of education in building a thriving ecosystem for biotechnology innovation. We reached a consensus that establishing an educational framework that fosters creativity and nurtures innovative talents, starting from elementary education, is crucial. The synergy between education and collaboration is imperative for a brighter future for Korea's biotechnology industry.


Die Kommentarfunktion wurde abgeschaltet.
bottom of page